Efficacy of stellate ganglion block in treatment of electrical storm: a systematic review and meta-analysis.

Humans Stellate Ganglion Autonomic Nerve Block / methods Treatment Outcome Ventricular Fibrillation / therapy Tachycardia, Ventricular / therapy
Electrical storm Meta-analysis Stellate ganglion block Systematic Review Ventricular Electrical Storm Ventricular arrhythmia

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 Oct 2024
Historique:
received: 09 06 2024
accepted: 15 10 2024
medline: 22 10 2024
pubmed: 22 10 2024
entrez: 21 10 2024
Statut: epublish

Résumé

Electrical storm (ES) is a life-threatening condition of recurrent ventricular arrhythmias (VA) in a short period of time. Percutaneous stellate ganglion blockade (SGB) is frequently used - however the efficacy is undefined. The objective of our systematic review was to determine the efficacy of SGB in reducing VA events and mortality among patients with ES. A search of Medline, EMBASE, Scopus, CINAHL and CENTRAL was performed on February 29, 2024 to include studies with adult patients (≥ 18 years) with ES treated with SGB. Our outcomes of interest were VA burden pre- and post-SGB, and in-hospital/30-day mortality. A total of 553 ES episodes in 542 patients from 15 observational studies were included. Treated VAs pre- and post-SGB were pooled from eight studies including 383 patients and demonstrated a decrease from 3.5 (IQR 2.25-7.25) to 0 (IQR 0-0) events (p = 0.008). Complete resolution after SGB occurred in 190 of 294 patients (64.6%). Despite this, in-hospital or 30-day mortality remained high occurring in 140 of 527 patients (random effects prevalence 22%). Repeat SGB for recurrent VAs was performed in 132 of 490 patients (random effects prevalence 21%). In conclusion, observational data suggests SGB may be effective in reducing VAs in ES. Definitive studies for SGB in VA management are needed. Study protocol: PROSPERO - registration number CRD42023430031.

Identifiants

DOI: 10.1038/s41598-024-76663-9 PMID: 39433834
pubmed: 39433834
doi: 10.1038/s41598-024-76663-9
pii: 10.1038/s41598-024-76663-9
doi:

Types de publication

Journal Article Systematic Review Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

24719

Informations de copyright

© 2024. The Author(s).

Références

Al-Khatib, S. M. et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the Prevention of Sudden Cardiac Death. Circulation. 138, e272–e391. https://doi.org/10.1161/CIR.0000000000000549 (2018).
doi: 10.1161/CIR.0000000000000549 pubmed: 29084731
Deyell, M. W. et al. Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients With Structural Heart Disease. Canadian Journal of Cardiology 36, 822–836, doi: (2020). https://doi.org/10.1016/j.cjca.2020.04.004 (2020).
Zeppenfeld, K. et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal 43, 3997–4126, doi: (2022). https://doi.org/10.1093/eurheartj/ehac262 (2022).
Jentzer, J. C. et al. Multidisciplinary critical Care Management of Electrical Storm. J. Am. Coll. Cardiol. 81, 2189–2206. https://doi.org/10.1016/j.jacc.2023.03.424 (2023).
doi: 10.1016/j.jacc.2023.03.424 pubmed: 37257955 pmcid: 10683004
Guerra, F. et al. Implantable cardioverter-defibrillator programming and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD). Heart Rhythm. 13, 1987–1992 (2016).
doi: 10.1016/j.hrthm.2016.06.007 pubmed: 27291511
Bode, F., Wiegand, U., Raasch, W., Richardt, G. & Potratz, J. Differential effects of defibrillation on systemic and cardiac sympathetic activity. Heart. 79, 560–567. https://doi.org/10.1136/hrt.79.6.560 (1998).
doi: 10.1136/hrt.79.6.560 pubmed: 10078082 pmcid: 1728717
Nademanee, K., Taylor, R., Bailey, W. E., Rieders, D. E. & Kosar, E. M. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation. 102, 742–747. https://doi.org/10.1161/01.cir.102.7.742 (2000).
doi: 10.1161/01.cir.102.7.742 pubmed: 10942741
Chatzidou, S. et al. Propranolol Versus Metoprolol for treatment of electrical storm in patients with Implantable Cardioverter-Defibrillator. J. Am. Coll. Cardiol. 71, 1897–1906. https://doi.org/10.1016/j.jacc.2018.02.056 (2018).
doi: 10.1016/j.jacc.2018.02.056 pubmed: 29699616
Gadhinglajkar, S., Sreedhar, R., Unnikrishnan, M. & Namboodiri, N. Electrical storm: role of stellate ganglion blockade and anesthetic implications of left cardiac sympathetic denervation. Indian J. Anaesth. 57, 397–400. https://doi.org/10.4103/0019-5049.118568 (2013).
doi: 10.4103/0019-5049.118568 pubmed: 24163457 pmcid: 3800335
Vaseghi, M. & Shivkumar, K. The role of the autonomic nervous system in sudden cardiac death. Prog. Cardiovasc. Dis. 50, 404 (2008).
doi: 10.1016/j.pcad.2008.01.003 pubmed: 18474284 pmcid: 2752648
Martins, R. P. et al. Effectiveness of deep sedation for patients with intractable electrical storm refractory to antiarrhythmic drugs. Circulation. 142, 1599–1601. https://doi.org/10.1161/CIRCULATIONAHA.120.047468 (2020).
doi: 10.1161/CIRCULATIONAHA.120.047468 pubmed: 33074763
Baldi, E. et al. Contemporary management of ventricular electrical storm in Europe: results of a European Heart Rhythm Association Survey. EP Europace. 25, 1277–1283. https://doi.org/10.1093/europace/euac151 (2022).
doi: 10.1093/europace/euac151
Zandstra, T. E. et al. Asymmetry and heterogeneity: Part and Parcel in Cardiac autonomic innervation and function. Front. Physiol. 12 https://doi.org/10.3389/fphys.2021.665298 (2021).
Narouze, S., Vydyanathan, A. & Patel, N. Ultrasound-guided stellate ganglion block successfully prevented esophageal puncture. Pain Physician. 10, 747–752 (2007).
doi: 10.36076/ppj.2007/10/747 pubmed: 17987096
Meng, L., Tseng, C. H., Shivkumar, K. & Ajijola, O. Efficacy of stellate ganglion blockade in managing electrical storm: a systematic review. JACC Clin. Electrophysiol. 3, 942–949. https://doi.org/10.1016/j.jacep.2017.06.006 (2017).
doi: 10.1016/j.jacep.2017.06.006 pubmed: 29270467 pmcid: 5734652
Moss, A. J. & McDonald, J. Unilateral Cervicothoracic Sympathetic Ganglionectomy for the treatment of long QT interval syndrome. N. Engl. J. Med. 285, 903–904. https://doi.org/10.1056/NEJM197110142851607 (1971).
doi: 10.1056/NEJM197110142851607 pubmed: 5112730
Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int. J. Surg. 88, 105906 (2021).
doi: 10.1016/j.ijsu.2021.105906 pubmed: 33789826
Sterne, J. A. C., McAleenan, H. M., Reeves, A. & Higgins, B. C. JPT. Chapter 25: Assessing risk of bias in a non-randomized study. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February (2022). (2022).
Sterne, J. A. et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 355, i4919. https://doi.org/10.1136/bmj.i4919 (2016).
doi: 10.1136/bmj.i4919 pubmed: 27733354 pmcid: 5062054
Ma, L. L. et al. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Military Med. Res. 7, 7. https://doi.org/10.1186/s40779-020-00238-8 (2020).
doi: 10.1186/s40779-020-00238-8
Dhanse, S. et al. Effectiveness of ultrasonography-guided cardiac sympathetic denervation in acute control of electrical storm: a retrospective case series. J. Anaesthesiol. Clin. Pharmacol. 38, 610–616. https://doi.org/10.4103/joacp.JOACP_16_21 (2022).
doi: 10.4103/joacp.JOACP_16_21 pubmed: 36778828
Halawa, A. et al. Heart Rhythm 18, S440–S441, doi: https://doi.org/10.1016/j.hrthm.2021.06.1087 (2021).
doi: 10.1016/j.hrthm.2021.06.1087
Kotti, K. et al. Ultrasound guided percutaneous left stellate ganglion block for ventricular arrhythmia storm in acute coronary syndrome following percutaneous coronary intervention: a case series. J. Arrhythmia. 35, 574–575. https://doi.org/10.1002/joa3.12276 (2019).
doi: 10.1002/joa3.12276
Lador, A. et al. Stellate ganglion instrumentation for pharmacological blockade, nerve recording, and stimulation in patients with ventricular arrhythmias: preliminary experience. Heart Rhythm. 20, 797–805. https://doi.org/10.1016/j.hrthm.2023.02.024 (2023).
doi: 10.1016/j.hrthm.2023.02.024 pubmed: 36863635
Markman, T. M. et al. Neuromodulation for the treatment of refractory ventricular arrhythmias. JACC: Clin. Electrophysiol. 9, 161–169. https://doi.org/10.1016/j.jacep.2022.08.031 (2023).
doi: 10.1016/j.jacep.2022.08.031 pubmed: 36858681
Jiravsky, O. et al. Early ganglion stellate blockade as part of two-step treatment algorithm suppresses electrical storm and need for intubation. Hellenic J. Cardiol. https://doi.org/10.1016/j.hjc.2023.04.003 (2023).
doi: 10.1016/j.hjc.2023.04.003 pubmed: 37088344
Pasula, A., Ghosh, A. & Pandurangi, U. M. PO-04-232 < strong > PERCUTANEOUS STELLATE GANGLION BLOCKADE FOR ELECTRICAL STORM: LARGE SINGLE CENTRE EXPERIENCE. Heart Rhythm. 20 https://doi.org/10.1016/j.hrthm.2023.03.1229 (2023).
Patel, R. A., Condrey, J. M., George, R. M., Wolf, B. J. & Wilson, S. H. Stellate ganglion block catheters for refractory electrical storm: a retrospective cohort and care pathway. Reg. Anesth. Pain Med. 48, 224–228. https://doi.org/10.1136/rapm-2022-104172 (2023).
doi: 10.1136/rapm-2022-104172 pubmed: 36725213 pmcid: 10251217
Reinertsen, E., Sabayon, M., Riso, M., Lloyd, M. & Spektor, B. Stellate ganglion blockade for treating refractory electrical storm: a historical cohort study. Can. J. Anaesth. 68, 1683–1689. https://doi.org/10.1007/s12630-021-02068-1 (2021).
doi: 10.1007/s12630-021-02068-1 pubmed: 34312821
Sanghai, S. et al. Stellate ganglion blockade with continuous infusion Versus single injection for treatment of ventricular arrhythmia storm. JACC Clin. Electrophysiol. 7, 452–460. https://doi.org/10.1016/j.jacep.2020.09.032 (2021).
doi: 10.1016/j.jacep.2020.09.032 pubmed: 33358672
Tian, Y. et al. Effective use of Percutaneous Stellate Ganglion Blockade in patients with Electrical Storm. Circ. Arrhythm. Electrophysiol. 12, e007118. https://doi.org/10.1161/circep.118.007118 (2019).
doi: 10.1161/circep.118.007118 pubmed: 31514529
Chouairi, F. et al. A Multicenter Study of Stellate Ganglion Block as a Temporizing treatment for refractory ventricular arrhythmias. JACC: Clin. Electrophysiol. https://doi.org/10.1016/j.jacep.2023.12.012 (2024).
doi: 10.1016/j.jacep.2023.12.012 pubmed: 38363278
Cardona, X. R., Butnaru, D. S. & Ribero, O. F. G. Bloqueo De Ganglio Estrellado como una estrategia de manejo en cuidado paliativo en paciente con arritmias cardíacas terminales: Serie De Casos. Rev. Chil. Anest. 53, 66–72 (2024).
Savastano, S. et al. Electrical storm treatment by percutaneous stellate ganglion block: the STAR study. Eur. Heart J. ehae021 https://doi.org/10.1093/eurheartj/ehae021 (2024).
Batnyam, U. et al. Safety and Efficacy of Ultrasound-guided sympathetic blockade by Proximal Intercostal Block in Electrical Storm patients. JACC: Clin. Electrophysiol. https://doi.org/10.1016/j.jacep.2023.12.006 (2024).
doi: 10.1016/j.jacep.2023.12.006 pubmed: 38869503
Savastano, S. et al. Electrical storm treatment by percutaneous stellate ganglion block: the STAR study. Eur. Heart J. 45, 823–833. https://doi.org/10.1093/eurheartj/ehae021 (2024).
doi: 10.1093/eurheartj/ehae021 pubmed: 38289867 pmcid: 10919918
Grossman, M. A. Cardiac arrhythmias in Acute Central Nervous System Disease: successful management with stellate ganglion block. Arch. Intern. Med. 136, 203–207. https://doi.org/10.1001/archinte.1976.03630020057012 (1976).
doi: 10.1001/archinte.1976.03630020057012 pubmed: 1247352
Kowlgi, G. N. & Cha, Y. M. Management of ventricular electrical storm: a contemporary appraisal. EP Europace. 22, 1768–1780. https://doi.org/10.1093/europace/euaa232 (2020).
doi: 10.1093/europace/euaa232
Goel, V. et al. Complications associated with stellate ganglion nerve block: a systematic review. Reg. Anesth. Pain Med. https://doi.org/10.1136/rapm-2018-100127 (2019).
doi: 10.1136/rapm-2018-100127 pubmed: 31085577 pmcid: 8998784
Guerra, F. et al. Abstract 18503: preliminary results from the Multicenter International Registry on Electrical Storm patients: the ELECTRA Study. Circulation. 136, A18503–A18503. https://doi.org/10.1161/circ.136.suppl_1.18503 (2017).
doi: 10.1161/circ.136.suppl_1.18503
Egawa, H., Okuda, Y., Kitajima, T. & Minami, J. Assessment of QT interval and QT dispersion following stellate ganglion block using computerized measurements. Reg. Anesth. Pain Med. 26, 539–544 (2001).
doi: 10.1053/rapm.2001.25935 pubmed: 11707793
Yokota, S., Taneyama, C. & Goto, H. Different effects of right and left stellate ganglion block on systolic blood pressure and heart rate. Open. J. Anesthesiology, 3(3), 143–147. https://doi.org/10.4236/ojanes.2013.33033 (2013).

Auteurs

Pouya Motazedian (P)

CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.

Nicholas Quinn (N)

Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

George A Wells (GA)

Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.

Nickolas Beauregard (N)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.

Eric Lam (E)

The Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Marie-Eve Mathieu (ME)

Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

William Knoll (W)

Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

Graeme Prosperi-Porta (G)

CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.

Valentina Ly (V)

Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

Simon Parlow (S)

CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

Pietro Di Santo (P)

CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

Omar Abdel-Razek (O)

CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.

Richard Jung (R)

CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

Trevor Simard (T)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester Minnesota, MN, USA.

Jacob C Jentzer (JC)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester Minnesota, MN, USA.

Rebecca Mathew (R)

Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.

F Daniel Ramirez (FD)

Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.

Benjamin Hibbert (B)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester Minnesota, MN, USA. Hibbert.Benjamin@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Efficacy of stellate ganglion block in...
questionsmedicales.fr › Système nerveux › Système nerveux périphérique › Système nerveux autonome › Système nerveux sympathique › Ganglions sympathiques › Ganglion cervicothoracique › Efficacy of stellate ganglion block in...
questionsmedicales.fr › Procédures de chirurgie opératoire › Procédures de neurochirurgie › Dénervation › Bloc nerveux › Bloc anesthésique du système nerveux autonome › Efficacy of stellate ganglion block in...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Efficacy of stellate ganglion block in...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Troubles du rythme cardiaque › Fibrillation ventriculaire › Efficacy of stellate ganglion block in...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Troubles du rythme cardiaque › Tachycardie › Tachycardie ventriculaire › Efficacy of stellate ganglion block in...